Research graph
References from Exploring traditional Chinese medicine to enhance the efficacy and reduce toxicity of immunotherapy for non-small cell lung cancer from the perspective of “spleen deficiency”: a trial protocol for mechanism and clinical evidence. Local targets link to admitted publications; unresolved targets remain external evidence.
Cancer statistics, 2026
10.3322/caac.70043 · 2026 · External reference
Nutritional status and its impact on treatment tolerance in non-small-cell lung cancer patients receiving osimertinib
10.3390/nu17050927 · 2025 · External reference
Neoadjuvant immunotherapy in non-small cell lung cancer: a narrative review on mechanisms, efficacy and safety
10.21037/jtd-22-1192 · 2022 · External reference
Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancer
10.1016/j.currproblcancer.2026.101311 · 2026 · External reference
The prognostic biological markers of immunotherapy for non-small cell lung cancer: current landscape and future perspective
10.3389/fimmu.2023.1249980 · 2023 · External reference
Addressing clinical needs in NSCLC immunotherapy: mechanisms of resistance and promising combination strategies
10.1016/j.xcrm.2025.102315 · 2025 · External reference
Efficacy and safety of neoadjuvant immunotherapy plus chemotherapy followed by adjuvant immunotherapy in resectable non-small cell lung cancer: a meta-analysis of phase 3 clinical trials
10.3389/fimmu.2024.1359302 · 2024 · External reference
Resistance to PD-1/PD-L1 immune checkpoint blockade in advanced non-small cell lung cancer
10.1016/j.critrevonc.2025.104683 · 2025 · External reference
Acquired resistance to immunotherapy by physical barriers with cancer cell-expressing collagens in non-small cell lung cancer
10.1073/pnas.2500019122 · 2025 · External reference
Hyperprogressive disease in non-small cell lung cancer after PD-1/PD-L1 inhibitors immunotherapy: underlying killer
10.3389/fimmu.2023.1200875 · 2023 · External reference
Traditional Chinese medicine in the era of immune checkpoint inhibitor: theory, development, and future directions
10.1186/s13020-023-00751-7 · 2023 · External reference
A bibliometric and visualization analysis of the role of traditional Chinese medicine in cancer immunotherapy
10.3389/fimmu.2025.1499026 · 2025 · External reference
Active ingredients of traditional Chinese medicine for enhancing the effect of tumor immunotherapy
10.3389/fimmu.2023.1133050 · 2023 · External reference
Traditional Chinese medicine enhances the effectiveness of immune checkpoint inhibitors in tumor treatment: a mechanism discussion
10.1016/j.jep.2024.118955 · 2025 · External reference
Roles of tissue-resident immune cells in immunotherapy of non-small cell lung cancer
10.3389/fimmu.2023.1332814 · 2023 · External reference
Evaluation of efficacy, safety and underlying mechanism on traditional Chinese medicine as synergistic agents for cancer immunotherapy: a preclinical systematic review and meta-analysis
10.1016/j.jep.2024.119035 · 2025 · External reference
The effectiveness of traditional Chinese medicine in treating Malignancies via regulatory cell death pathways and the tumor immune microenvironment: a review of recent advances
10.1142/s0192415x2450006x · 2024 · External reference
The traditional Chinese medicine and non-small cell lung cancer: from a gut microbiome perspective
10.3389/fcimb.2023.1151557 · 2023 · External reference
Clinical observation of “Jianpi Guchang decoction” on intestinal barrier function of chemotherapy patients with cancer at stage III and IV
10.16306/j.1008-861x.2017.02.007 · 2017 · External reference
Effect of Jianpi Guchang recipe on intestinal inflammatory response after chemotherapy in intestinal carcinoma mice by enhancing abundanceof short-chain fatty acid producing bacteria
2020 · External reference
Study on the mechanism of Jianpi Guchang formula on regulating short chain fatty acid metabolism on protecting intestinal barrier to exert anti-tumor effects
10.19945/j.cnki.issn.1006-3250.2025.06.022 · 2025 · External reference
Distribution of TCM syndromes in 121 cases of stage IIIB/IV non-small cell lung cancer
10.13192/j.ljtcm.2011.12.109.hewf.083 · 2011 · External reference
Traditional Chinese medicine for cancer treatment
10.1142/s0192415x24500253 · 2024 · External reference
Tumor-associated macrophages in tumor progression and the role of traditional Chinese medicine in regulating TAMs to enhance antitumor effects
10.3389/fimmu.2022.1026898 · 2022 · External reference
Targeted modulation of myeloid-derived suppressor cells in the tumor microenvironment: implications for cancer therapy
10.1016/j.biopha.2024.117590 · 2024 · External reference
The role of metabolic reprogramming in cancer metastasis and potential mechanism of traditional Chinese medicine intervention
10.1016/j.biopha.2022.113376 · 2022 · External reference
Applications of traditional Chinese medicine in cancer immunotherapy via gut microbiota modulation: current status, mechanisms, challenges and perspectives
10.1016/j.phrs.2025.108020 · 2025 · External reference
Traditional Chinese medicine (TCM) enhances the therapeutic efficiency of a gemcitabine-loaded injectable hydrogel on postoperative breast cancer through modulating the microenvironment
10.1039/d4tb02776k · 2025 · External reference
Immunometabolism at the service of traditional Chinese medicine
10.1016/j.phrs.2022.106081 · 2022 · External reference
Traditional Chinese medicines for non-small cell lung cancer: therapies and mechanisms
10.1016/j.chmed.2023.05.004 · 2023 · External reference
Traditional Chinese medicine in lung cancer treatment
10.1186/s12943-025-02245-6 · 2025 · External reference
Role of traditional Chinese medicine in lung cancer management: a review
10.1142/s0192415x25500053 · 2025 · External reference
Total ginsenoside wild ginseng root improves spleen qi deficiency by regulating intestinal microbes and flora metabolites
10.1016/j.arabjc.2023.105232 · 2023 · External reference
Gut dysbiosis and intestinal barrier dysfunction: potential explanation for early-onset colorectal cancer
10.3389/fcimb.2021.744606 · 2021 · External reference
Clinical efficacy and gut microbiota regulating-related effect of Si-Jun-Zi decoction in postoperative non-small cell lung cancer patients: a prospective observational study
10.1177/15347354241237973 · 2024 · External reference
Sijunzi decoction alleviates inflammation and intestinal epithelial barrier damage and modulates the gut microbiota in ulcerative colitis mice
10.3389/fphar.2024.1360972 · 2024 · External reference
Deep-fried Atractylodes lancea rhizome alleviates spleen deficiency diarrhea-induced short-chain fatty acid metabolic disorder in mice by remodeling the intestinal flora
10.1016/j.jep.2022.115967 · 2023 · External reference
Exploring the relationship between intestinal microbiota and immune checkpoint inhibitors in the treatment of non-small cell lung cancer: insights from the "lung and large intestine stand in exterior-interior relationship" theory
10.3389/fcimb.2024.1341032 · 2024 · External reference
Yangyin Fuzheng Jiedu prescription exerts anti-tumor immunity in hepatocellular carcinoma by alleviating exhausted T cells
10.1016/j.phymed.2021.153722 · 2021 · External reference
Polysaccharides from Astragalus membranaceus elicit T cell immunity by activation of human peripheral blood dendritic cells
10.1016/j.ijbiomac.2022.11.048 · 2022 · External reference
Ginsenoside Rg3 inhibits angiogenesis in gastric precancerous lesions through downregulation of Glut1 and Glut4
10.1016/j.biopha.2021.112086 · 2022 · External reference
Network medicine-based strategy identifies maprotiline as a repurposable drug by inhibiting PD-L1 expression via targeting SPOP in cancer
10.1002/advs.202410285 · 2025 · External reference
GEMap: a comprehensive gene essentiality map for drug discovery
10.1016/j.apsb.2026.02.004 · 2026 · External reference
GSFM: a genome-scale functional module transformation to represent drug efficacy for in silico drug discovery
10.1016/j.apsb.2024.08.017 · 2025 · External reference
COIMMR: a computational framework to reveal the contribution of herbal ingredients against human cancer via immune microenvironment and metabolic reprogramming
10.1093/bib/bbad346 · 2023 · External reference
Tailoring traditional Chinese medicine in cancer therapy
10.1186/s12943-024-02213-6 · 2025 · External reference
The interactions between traditional Chinese medicine and gut microbiota in cancers: current status and future perspectives
10.1016/j.phrs.2024.107148 · 2024 · External reference
Exploring the potential use of Chinese herbs in regulating the inflammatory microenvironment of tumours based on the concept of 'state-target identification and treatment': a scooping review
10.1186/s13020-023-00834-5 · 2023 · External reference
